Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Atlas Copco has acquired a compressor distributor in the Southwest of France

Nacka, Sweden, July 5: Atlas Copco has acquired FITEC S.A.S., a French distributor of compressors. The company is specialized in the sales and service of rotary screw compressors and ancillary equipment and mainly sells to small and medium-sized industries.FITEC is a privately owned company and is based in Tarnos close to Bayonne in the Southwest of France. The company has 8 employees. “This acquisition is an opportunity to strengthen our presence in the Southwest area of France”, said Vagner Rego, Business Area President Compressor Technique. The purchase price is not disclosed.

Citycon purchases an additional EUR 20 million notional amount of bonds resulting in total year-to-date notional bond repurchases of approximately EUR 79 million

CITYCON OYJ   Investor News 5 July 2022 at 10:00 hrsCitycon purchased an additional notional amount of approx. EUR 20 million of its bond maturing in 2027. In the last three weeks, Citycon repurchased a total notional amount of EUR 54 million of its bonds for approximately EUR 50 million in cash.  This brings its year-to-date notional repurchases to approx. EUR 79 million using approx. EUR 75 million of cash. “These additional bond repurchases further reduce interest expense, strengthen our strong credit profile, lower refinancing risk and improve our well-laddered maturity schedule.  In

SRV Group Plc has executed a reverse share split

SRV GROUP PLC     STOCK EXCHANGE RELEASE     5 JULY 2022      10:00 EEST SRV Group Plc has executed a reverse share split SRV Group Plc (“SRV” or “Company”) has on the previously announced reverse split date, 4 July 2022, executed a reverse share split and thereto related directed share issue without consideration, redemption of shares and cancellation of shares. After these measures, the new number of shares in the Company is 16,982,343. The new number of shares has been registered with the Trade Register maintained by the Finnish Patent and Registration Office on 4 July 2022, and

AcuCort launches new website

AcuCort AB (publ) (Spotlight Stock Market: ACUC) announced today that the company’s new website with improved functions as well as with new graphic identity and updated content has been launched.As part of ensuring good functionality and visualizing that AcuCort takes further steps in its development, the company has developed a new website. The website now offers, for example, functions such as a subscription service for the company's press releases and financial reports, as well as improved IR and corporate governance pages. Other content has also been updated. Please visit www.acucort.se.

Wallenberg Investments comments on SAS decision to enter into a legal process for financial restructuring, via Chapter 11

We note the announcement made today by the SAS Board of directors and Management team to initiate a controlled restructuring according to American law, also known as a ”Chapter 11” process. For decades, SAS have been burdened with costs too high compared to its competitors, something which the Company has attempted to address.After the pandemic, which affected the aviation market both in terms of volumes and distribution between business and leisure travel, the effort to reach a lower debt burden, competitive cost structure and flexibility in the Company’s operations has been intensified

Success for Polygiene Group at Aircraft Interiors Expo

Polygiene Group exhibited for the first time at the AIX show in Hamburg in June with a booth that stood out in the crowd and showed why Polygiene technologies adds important value to aircraft interiors. In addition to a large number of leads and meetings, Polygiene participated in a panel discussion with the Polygiene CMO, the ‘Germ guy’ Jason Tetro, moderator Paul Chen from VX Consulting and partner MGR Foamtex on 'How to Improve Cabin Interior Hygiene’ and was mentioned in several trade magazines including PAX International. The participation at AIX, the world’s leading marketplace

Partnership between Danish DecideAct and London-based Digitopia aims to speed up digital transformation in large organizations

The Strategy Execution software company DecideAct enters a strategic partnership with the London-based digital maturity consultancy Digitopia, which will use DecideAct's platform to support the effective and efficient execution of the change processes it initiates with clients. The collaboration is initially focusing on Turkey and the Middle East.Digitopia is a leading digital maturity consultancy headquartered in London with a business focus on Turkey and the Middle East. The company offers independent expertise and advice in digital transformation and sustainability and has transformed

Krea has now launched Revolving Credit together with selected lenders - an effort to make flexible financing available to more companies

The current economic landscape is volatile, to say the least, making it hard for companies to predict, and plan for changes in their ongoing operations. As the general unease on the market accelerates, increased demand for flexible financing is becoming more prominent. For this reason, Krea has now launched Revolving Credit as a flexible option for financing together with selected lenders. The launch of revolving credit will grant more companies easy access to flexible financing on the best possible terms.An unsteady market  In the turmoil of the Covid-19 pandemic, and with a strong

BioStock: Last patient dosed in Respiratorius’ PK study with VAL001

Respiratorius finished June with good news announcing that the last patient had been dosed in the pharmacokinetic study with VAL001. The drug candidate against diffuse large B-cell lymphoma , VAL001, has undergone a clinical study to evaluate the tailor-made release profile before a phase III study can be initiated. BioStock took the opportunity to ask CEO Johan Drott a few of questions.Read the full article at biostock.se:https://www.biostock.se/en/2022/07/last-patient-dosed-in-respiratorius-pk-study-with-val001/This is a press release from BioStock - Connecting Innovation & Capital.

Nurminen Logistics establishes two new share-based long-term incentive plans

Nurminen Logistics Plc      Stock Exchange Release July 5, 2022, at 9.30 am The Board of Directors of Nurminen Logistics Plc has decided to establish two new share-based incentive plans for the key employees of the company. The objective of the plans is to align the interests of the key employees and Nurminen Logistics shareholders and to increase the company value in the long term, to drive financial and operative performance, and to retain key employees by offering them a competitive performance-based earning opportunity. Performance Share Plan 2022–2026 The Performance Share

Atlas Copco’s Q2 report 2022 and invitation to the conference call, July 19

Nacka, Sweden, July 5, 2022: Atlas Copco will publish its Q2 results for 2022 on Tuesday, July 19, at approximately 12:00 AM CEST. A conference call for investors, analysts and media will be held at 1:00 PM CEST.Participating from Atlas Copco will be Mats Rahmström, President and CEO, and Peter Kinnart, CFO. The conference call will begin with a short presentation of the report followed by a question-and-answer session. The conference call will be broadcasted live on the web. Please see our website www.atlascopcogroup.com/investor-relations for the webcast link and presentation material.

Nurminen Logistics Plc to issue new shares in the company to the company itself without consideration

Nurminen Logistics Plc      Stock Exchange Release July 5, 2022, at 9.30 am The Board of Directors of Nurminen Logistics Plc (the “Company”) has, pursuant to the authorization granted to it by the Annual General Meeting held on 11 April 2022, yesterday evening resolved to issue 133,078 new shares in the Company to the Company itself without consideration in accordance with Chapter 9, Section 20 of the Finnish Companies Act (624/2006, as amended). The new shares to be issued are of the same class as the existing shares in the Company. The total number of the Company’s shares after the

Epiroc trials first-ever battery-electric surface drill rig

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and Infrastructure industries, has agreed with Swedish construction company Skanska to field test the world’s first battery-electric drill rig for surface operations. The trial is a milestone in the journey towards zero-emission drilling in surface mines and quarries around the world.Epiroc is taking a major step with the inaugural battery-powered drill rig for surface operations. The design of the rig is based on Epiroc’s well-proven SmartROC T35 surface drill rig. Using Epiroc’s vast experience

Netmore LoRaWAN expands to Switzerland through roaming agreement

Netmore and Swiss telecoms provider Swisscom have signed a cooperation agreement which concerns roaming between their respective IoT networks (LoRaWAN). Netmore’s Swedish and international customers will gain full access to Swisscom’s nationwide network in Switzerland, while Swisscom will be able to offer Netmore’s growing LoRaWAN coverage to its customers.Netmore continues to grow – customers and partners gain nationwide LoRaWAN coverage in Switzerland The roaming agreement between Netmore and Swisscom means that Netmore customers will now be able to connect devices on Swisscom’s

World’s widest portfolio of natural colors gets even stronger: Oterra acquires India’s Akay Group

Oterra, the world’s leading supplier of natural colors, further strengthens its core offerings with the acquisition of Akay Group, a prominent natural ingredients manufacturer. Founded in India in 1995, Akay Group is a leading player in the natural colors and nutraceutical ingredients industry.The acquisition, Oterra’s fourth in only 14 months, is a win-win for both parties. Oterra will not only strengthen its access to natural colors but also to an attractive product pipeline backed by state-of-the-art manufacturing plants and strong R&D capabilities. “Akay is a great strategic match

NIB helps finance Danish hearing healthcare technology

The Nordic Investment Bank (NIB) and the Danish hearing healthcare company Demant A/S have signed a new 7-year loan agreement of DKK 750 million (EUR 100.80 million) to help finance the company’s audiological devices and technology research investments.Demant has a very significant and comprehensive R&D programme, and a very large portion of this is carried out in close cooperation with several universities, research centers and companies in Denmark. “Demant’s investments into R&D will have a positive effect on the quality of life for people suffering from hearing disabilities, enabling

Alzinova establishes scaled-up manufacturing process for ALZ-101 ahead of Phase 2

Alzinova AB (publ) (“Alzinova” or “the Company”) announces today that the Company has successfully verified that the manufacturing process for vaccine doses of ALZ-101, the Company’s vaccine candidate against Alzheimer’s disease, can be scaled up to deliver larger production volumes required for clinical phase 2 trials.Preparations for clinical phase 2 development are progressing successfully and the Company has now verified that the manufacturing process can produce larger volumes of Alzinova's Alzheimer's vaccine candidate ALZ-101. Earlier this year, Alzinova announced that it had already

AstraZeneca to acquire TeneoTwo and T cell engager

5 July 2022 07:00 BST AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager, strengthening haematological cancer pipeline TNB-486 will be evaluated in multiple types of lymphoma AstraZeneca today announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)[i], including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluation in relapsed and refractory B-cell non-Hodgkin lymphoma[1]. The acquisition of TNB-486 aims to accelerate the development of this potential new medicine for B-cell haematologic malignancies, including diffuse

Invitation to conference call with web presentation of Cloetta AB´s interim report Q2 2022

Cloetta AB will publish the interim report for the period 1 April – 30 June 2022 on Friday 15 July 2022 at 8 a.m. CEST. Following this report Cloetta will organize a conference call with web presentation for media and the financial community.President and CEO Henri de Sauvage Nolting and CFO Frans Rydén will present and comment on the report. After the presentation there will be time for questions, both on the phone and in the web presentation. Time for the publication of the interim reportFriday 15 July at 08:00 a.m. CEST  Time for conference call and web presentationFriday 15

Invitation to the presentation of Swedbank’s Interim report January – June 2022

Swedbank’s Interim report for the second quarter 2022 will be published on Tuesday 19 July at 7.00 a.m. CET.Investors and analysts: Conference call on 19 July at 9.00 a.m. CET Jens Henriksson (President and CEO), Anders Karlsson (CFO), Rolf Marquardt (CRO) and Annie Ho (Head of Investor Relations) will present the report. The conference call will be held in English and broadcasted live on www.swedbank.com/ir, where a recording also will be available following the call. To participate in the conference call, dial:Sweden: +46 8 5055 8373United Kingdom: +44 333 300 9267United

MSAB offers increasingly accessible digital evidence to maximize investigative effectiveness

MSAB, a world leader in mobile forensics, announces its second major release for 2022. Together these updates create a complete security and integrity focused ecosystem.“The MSAB vision is to empower every investigation with digital forensic solutions – for a safer world. We have been striving to arm our customers with the right solutions that allow access to critical information in the first hours of a criminal investigation and reduce time spent collecting digital evidence whilst emphasizing the right to privacy for victims”, says Joel Bollö, CEO of MSAB. The updated mobile forensics

Viaplay becomes home of Hoofdklasse field hockey in the Netherlands

· Viaplay to stream nearly 300 live matches a season of the Netherlands’ second-largest team sport · Women’s and men’s Hoofdklasse ranked among the world’s leading field hockey leagues · Viaplay, HHcv and KNHB to work together to broaden fan reach of both competitions Viaplay has secured the exclusive streaming rights to Hoofdklasse field hockey in the Netherlands in a pioneering long-term agreement with the Hockey Hoofdklasse CV (HHcv), supported by the Royal Dutch Hockey Association (KNHB), which aims to bring the country’s second-largest team sport by participation to a broad

SBB divests residential property in Örebro to an agreed property value of SEK 400 million

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) is selling the residential property Gasugnen 24 in Örebro to Husherren at an agreed property value of SEK 400 million. The property has a total lettable area of 10,543 sqm, of which 9,023 sqm consists of residentials. Total rental income for 2022 excluding surcharges is estimated at SEK 20.3 million. “We have had challenges in achieving sufficient management volume in residential properties in Örebro and our main priority now is strengthened credit ratios. It also feels important that the buyer is a professional and long-term local

Orexo’s nasal adrenaline rescue medication OX640 enters clinical development

· OX640 has the potential to provide important benefits to patients and healthcare systems ensuring the correct adrenaline dose is both reliably and conveniently available - for the emergency treatment of allergic reactions · If approved, the product will target a global growing market, today amounting to USD 2 billion  · Development and commercial partnerships are considered Uppsala, Sweden – July 5, 2022 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces it has successfully initiated the first explorative human clinical study (OX640-001) for OX640, an adrenaline rescue

There are no items matching the current filter
There are no more items matching the current filter
Back to top